Pain Therapeutics reported $2.82M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US USD 2.83B 98M
Acelrx Pharmaceuticals ACRX:US USD 5.26M 1.56M
Amgen AMGN:US USD 1.47B 181M
Biogen BIIB:US USD 563.3M 9.3M
Cara Therapeutics CARA:US USD 6.88M 658K
Eisai 4523:JP JPY 88.08B 4.22B
Eli Lilly And LLY:US USD 1.64B 29M
Geron GERN:US USD 15.64M 8.2M
Johnson & Johnson JNJ:US USD 6.51B 423M
Merk MRK:US USD 2.63B 134M
Novartis NOVN:VX USD 3.4B 185M
Novavax NVAX:US USD 122.88M 14.72M
Pain Therapeutics PTIE:US USD 2.82M 150K
Pfizer PFE:US USD 4.87B 1.33B
Roche Holding ROG:VX 5.64B 899M